Bill
AB 1172
Overview: AB 1172 allows adult day programs to administer intranasal emergency antiseizure medications to participants.Purpose and Intent: The bill aims to improve the safety and c
Overview: AB 1172 allows adult day programs to administer intranasal emergency antiseizure medications to participants.
Purpose and Intent: The bill aims to improve the safety and care of individuals with seizure disorders who attend adult day programs. It seeks to empower program staff to respond quickly and effectively to seizure emergencies, potentially preventing serious complications or even saving lives.
Key Provisions:
- Authorizes adult day programs to administer intranasal emergency antiseizure medications to participants
- Requires program staff to receive appropriate training and follow established protocols for medication administration
- Provides liability protections for staff who administer the medications in good faith during emergencies
Affected Parties and Impacts: The bill directly affects adult day program participants with seizure disorders, their families, and the staff who provide care at these facilities. It enhances the ability of programs to manage seizure emergencies and support the health and well-being of their participants.
Procedural and Timeline Considerations: The bill has been chaptered by the Secretary of State, meaning it has been signed into law and will take effect on the specified date.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
